National Health Company Top Insiders

NHI Stock  USD 74.70  1.36  1.85%   
National Health employs about 30 people. The company is managed by 18 executives with a total tenure of roughly 157 years, averaging almost 8.0 years of service per executive, having 1.67 employees per reported executive. Assessment of National Health's management performance can provide insight into the firm performance.
Eric Mendelsohn  CEO
CEO President
John Spaid  President
Chief Financial Officer, Executive Vice President - Finance
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

National Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with National Health's future performance. Based on our forecasts, it is anticipated that National will maintain a workforce of under 30 employees by April 2025.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

National Health Management Team Effectiveness

The company has Return on Asset of 0.0463 % which means that on every $100 spent on assets, it made $0.0463 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1028 %, implying that it generated $0.1028 on every 100 dollars invested. National Health's management efficiency ratios could be used to measure how well National Health manages its routine affairs as well as how well it operates its assets and liabilities. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Return On Assets is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.09. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Debt To Assets is estimated to increase to 0.44, while Total Assets are projected to decrease to under 1.4 B.
The National Health's current Net Income Applicable To Common Shares is estimated to increase to about 102.4 M, while Common Stock Shares Outstanding is projected to decrease to under 32.5 M.

National Health Workforce Comparison

National Health Investors is rated below average in number of employees category among its peers. The total workforce of Real Estate industry is now estimated at about 1,663. National Health claims roughly 30.0 in number of employees contributing just under 2% to equities listed under Real Estate industry.

National Health Profit Margins

The company has Net Profit Margin of 0.41 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.63 %, which entails that for every 100 dollars of revenue, it generated $0.63 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin1.081.11
Fairly Down
Slightly volatile
Net Profit Margin0.440.5363
Significantly Down
Slightly volatile
Operating Profit Margin0.70.8356
Fairly Down
Slightly volatile
Pretax Profit Margin0.670.5363
Fairly Up
Slightly volatile
Return On Assets0.08140.0527
Way Up
Slightly volatile
Return On Equity0.09580.1009
Notably Down
Slightly volatile

National Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific National Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on National Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, National Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
8.5
17
2
 171,167 
 534.00 
2024-09-01
1.0909
48
44
 719,966 
 1,029,136 
2024-06-01
1.0
1
1
 437.00 
 230.00 
2022-09-01
0.6667
2
3
 19,833 
 52,731 
2022-06-01
2.0
2
1
 50,000 
 0.00 
2021-09-01
10.0
10
1
 10,468 
 45,307 
2021-03-01
5.6667
17
3
 386,669 
 49,844 
2020-03-01
1.25
35
28
 699,625 
 661,150 
2019-12-01
0.3333
1
3
 16,668 
 31,886 
2019-09-01
0.2
1
5
 16,666 
 34,061 
2019-03-01
1.1852
32
27
 650,001 
 645,026 
2018-12-01
0.6667
8
12
 158,332 
 261,454 
2018-09-01
0.625
5
8
 90,000 
 149,494 
2018-06-01
1.0
4
4
 54,453 
 88,548 
2017-12-01
1.0
1
1
 263.00 
 0.00 
2017-09-01
0.5
5
10
 66,925 
 126,583 
2017-06-01
0.5
2
4
 29,166 
 54,833 
2017-03-01
10.0
20
2
 385,000 
 24,593 
2016-09-01
0.6154
8
13
 126,664 
 217,084 
2016-06-01
0.5926
16
27
 270,001 
 460,081 
2016-03-01
2.0
18
9
 315,002 
 169,218 
2015-12-01
2.0
4
2
 17,833 
 29,787 
2015-03-01
1.037
28
27
 658,734 
 641,782 
2014-03-01
10.0
10
1
 226,858 
 400.00 
2013-03-01
5.5
11
2
 231,668 
 9,909 
2012-12-01
0.35
7
20
 125,000 
 239,601 
2012-09-01
0.5
5
10
 116,665 
 214,395 
2012-06-01
0.3
6
20
 155,000 
 339,768 
2012-03-01
0.9412
16
17
 365,835 
 259,201 
2011-12-01
0.3
3
10
 35,834 
 60,407 
2011-09-01
0.8182
9
11
 112,500 
 180,678 
2011-03-01
1.5
12
8
 248,333 
 68,384 
2010-09-01
0.5
4
8
 88,333 
 157,451 
2010-06-01
0.5
10
20
 114,330 
 202,901 
2010-03-01
1.6
16
10
 410,834 
 85,129 
2009-12-01
0.2143
3
14
 100,030 
 367,617 
2009-09-01
0.3636
4
11
 39,166 
 98,017 
2009-06-01
0.5
1
2
 15,000 
 27,219 
2009-03-01
8.0
8
1
 198,334 
 3,000 
2008-09-01
0.6
3
5
 14,343 
 70,000 
2008-06-01
2.5
5
2
 64,771 
 48,333 
2008-03-01
0.9286
13
14
 159,186 
 199,860 
2007-06-01
5.0
5
1
 75,000 
 725.00 
2006-06-01
2.5
5
2
 75,000 
 30,000 
2005-12-01
1.0
1
1
 15,000 
 15,000 
2005-03-01
1.375
11
8
 154,721 
 100,521 
2004-12-01
0.5455
6
11
 41,375 
 41,375 
2004-06-01
1.5
9
6
 116,000 
 72,860 
2003-12-01
0.5
2
4
 54,617 
 143,234 
2003-09-01
0.8
4
5
 107,750 
 113,350 

National Health Notable Stakeholders

A National Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as National Health often face trade-offs trying to please all of them. National Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting National Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Eric MendelsohnCEO PresidentProfile
John SpaidChief Financial Officer, Executive Vice President - FinanceProfile
D MendelsohnExecutive Vice President - Corporate FinanceProfile
Kevin PascoeExecutive VP of InvestmentsProfile
Robert AdamsIndependent DirectorProfile
James JobeIndependent DirectorProfile
Robert WebbIndependent DirectorProfile
Dana HamblyDirector of Investor RelationsProfile
Robert McCabeIndependent DirectorProfile
Kimberly OuimetDirector ResourcesProfile
Colleen SchallerDirector of Investor RelationsProfile
Charlotte SwaffordIndependent DirectorProfile
David TravisSenior Vice President Chief Accounting OfficerProfile
Beth BlankenshipSenior AffairsProfile
W AdamsIndependent Chairman of the BoardProfile
Michelle KellySenior InvestmentsProfile
Susan SidwellCorporate SecretaryProfile
Kristin GainesChief Credit OfficerProfile

About National Health Management Performance

The success or failure of an entity such as National Health Investors often depends on how effective the management is. National Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of National management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the National management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.05  0.08 
Return On Capital Employed 0.10  0.09 
Return On Assets 0.05  0.08 
Return On Equity 0.10  0.10 

National Health Workforce Analysis

Traditionally, organizations such as National Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare National Health within its industry.

National Health Manpower Efficiency

Return on National Health Manpower

Revenue Per Employee8.6M
Revenue Per Executive14.3M
Net Income Per Employee4.6M
Net Income Per Executive7.6M

Complementary Tools for National Stock analysis

When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stocks Directory
Find actively traded stocks across global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine